Pfizer completes Hospira deal; Synedgen manufacturing director publishes research; Nigeria adds drug warehouse;

> Pfizer ($PFE) has completed its $15 billion buyout of Hospira. Release

> Synedgen Director of Manufacturing Christopher Ryan contributed to research with the CDC and universities on Trichomonas vaginalis. Release

> Nigeria is building a "warehouse in a box" to help the country deal with drug-distribution problems. Story

Suggested Articles

The FDA has lambasted the Torrent Pharmaceuticals in a warning letter for making OTC meds using water tainted with bacteria.

Eli Lilly is investing $400 million in its Indianapolis site to expand production of insulin and other diabetes meds, and add 100 jobs.

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.